SCHEMBL7547287

SCHEMBL7547287

C=C(C)C(=O)C(N)CCCCC(N)C(=O)CN

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSR P00390 1/20 0.38
▸ NOS2 P35228 5/20 0.35
▸ NOS1 P29475 4/20 0.35
▸ NOS3 P29474 3/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ BLM P54132 1/20 0.34
▸ METAP1 P53582 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ GNAI3 P08754 1/20 0.32
▸ GNAO1 P09471 1/20 0.32
▸ GNAI1 P63096 1/20 0.32
▸ ARG1 P05089 3/20 0.32
▸ ARG2 P78540 3/20 0.32
▸ DPP7 Q9UHL4 4/20 0.31
▸ DPP4 P27487 1/20 0.31
▸ DPP8 Q6V1X1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1437432 0.85 GSR (0.55) GSRNOS2NOS1NOS3CYP1A2
SCHEMBL7546678 0.83 GSR (0.53) GSRNOS2GNAI3GNAO1GNAI1
SCHEMBL28989917 0.79 GRIK1 (0.47) TSHRGNAI3GNAO1GNAI1DPP7
SCHEMBL28989906 0.79 GRIK1 (0.47) TSHRGNAI3GNAO1GNAI1DPP7
SCHEMBL28989897 0.79 GRIK1 (0.47) TSHRGNAI3GNAO1GNAI1DPP7
SCHEMBL28989949 0.79 GRIK1 (0.47) TSHRGNAI3GNAO1GNAI1DPP7
SCHEMBL27791383 0.78 DPP7 (0.39) GSRTSHRDPP7DPP4DPP8
SCHEMBL7024850 0.78 ALDH1A1 (0.49) GSRCYP1A2TSHR
SCHEMBL5961633 0.77 NOS2 (0.50) GSRNOS2NOS1NOS3CYP1A2
SCHEMBL18499975 0.76 GSR (0.64) GSRGNAI3GNAO1GNAI1DPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0941123-B1 NUCLEIC ACID COMPLEXED WITH CATIONIC POLYMER USEFUL FOR GENE THERAPY HYBRID SYSTEMS LTD (GB) 2002-06-12 — — EP claimed
US-6312727-B1 SYNTHETIC POLYMER CARRIER VEHICLE FOR DELIVERY OF NUCLEIC ACID TO TARGET CELLS IN BIOLOGICAL SYSTEMS HYBRID SYSTEMS LIMITED (GB) 2001-11-06 — — US claimed
EP-0941123-A2 DELIVERY OF NUCLEIC ACID MATERIAL TO TARGET CELLS IN BIOLOGICAL SYSTEMS SCHACHT, Etienne Honoré (BE) 1999-09-15 — — EP claimed
WO-1998019710-A2 DELIVERY OF NUCLEIC ACID MATERIAL TO TARGET CELLS IN BIOLOGICAL SYSTEMS SCHACHT ETIENNE HONORE (BE) 1998-05-14 — — WO claimed
EP-0941123-B1 NUCLEIC ACID COMPLEXED WITH CATIONIC POLYMER USEFUL FOR GENE THERAPY HYBRID SYSTEMS LTD (GB) 2002-06-12 — — EP disclosed
US-6312727-B1 SYNTHETIC POLYMER CARRIER VEHICLE FOR DELIVERY OF NUCLEIC ACID TO TARGET CELLS IN BIOLOGICAL SYSTEMS HYBRID SYSTEMS LIMITED (GB) 2001-11-06 — — US disclosed
EP-0941123-A2 DELIVERY OF NUCLEIC ACID MATERIAL TO TARGET CELLS IN BIOLOGICAL SYSTEMS SCHACHT, Etienne Honoré (BE) 1999-09-15 — — EP disclosed
WO-1998019710-A2 DELIVERY OF NUCLEIC ACID MATERIAL TO TARGET CELLS IN BIOLOGICAL SYSTEMS SCHACHT ETIENNE HONORE (BE) 1998-05-14 — — WO disclosed
Send feedback